TLP
ELV icon

Tri Locum Partners’s Elevance Health ELV Stock Holding History

Tri Locum Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-568
Closed -$247K – 32
2023
Q3 		$247K Buy
+568
New +$258K 0.08% 40
2021
Q1 		– Sell
-23,374
Closed -$7.5M – 52
2020
Q4 		$7.5M Buy
+23,374
New +$7.17M 2.73% 12

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tri Locum Partners's ELV Position: Q4 2023 in Review

Tri Locum Partners sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 568 shares — an estimated $247K sold.

Tri Locum Partners first reported a position in ELV in Q4 2020 and held it in 2 quarters. The position peaked at $7.5M in Q4 2020. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Tri Locum Partners reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Tri Locum Partners sold 568 Elevance Health shares in Q4 2023, an estimated $247K.
  • Tri Locum Partners first reported a position in Elevance Health in Q4 2020 and held it in 2 quarters.
  • Tri Locum Partners's Elevance Health position peaked at $7.5M in Q4 2020.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Tri Locum Partners's 13F filing for Q4 2023, filed 14 Feb 2024.